Home Cart 0 Sign in  
X

[ CAS No. 24589-98-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 24589-98-8
Chemical Structure| 24589-98-8
Chemical Structure| 24589-98-8
Structure of 24589-98-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 24589-98-8 ]

Related Doc. of [ 24589-98-8 ]

Alternatived Products of [ 24589-98-8 ]

Product Details of [ 24589-98-8 ]

CAS No. :24589-98-8 MDL No. :MFCD17015455
Formula : C9H8O4 Boiling Point : -
Linear Structure Formula :- InChI Key :OMCTZIDLDSYPOA-UHFFFAOYSA-N
M.W : 180.16 Pubchem ID :14395860
Synonyms :

Calculated chemistry of [ 24589-98-8 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.11
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 45.13
TPSA : 63.6 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.87 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.4
Log Po/w (XLOGP3) : 0.75
Log Po/w (WLOGP) : 0.99
Log Po/w (MLOGP) : 0.7
Log Po/w (SILICOS-IT) : 1.39
Consensus Log Po/w : 1.05

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.57
Solubility : 4.82 mg/ml ; 0.0267 mol/l
Class : Very soluble
Log S (Ali) : -1.67
Solubility : 3.9 mg/ml ; 0.0216 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.85
Solubility : 2.57 mg/ml ; 0.0143 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.42

Safety of [ 24589-98-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 24589-98-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 24589-98-8 ]
  • Downstream synthetic route of [ 24589-98-8 ]

[ 24589-98-8 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 67-56-1 ]
  • [ 619-12-5 ]
  • [ 24589-98-8 ]
YieldReaction ConditionsOperation in experiment
100% at 60℃; for 3 h; Step 1:
Synthesis of methyl 4-formyl-3-hydroxybenzoate (239)
4-Formyl-3-hydroxybenzoic acid (1.2 g, 7.22 mmol) was dissolved in MeOH (10 ml). SOCl2 (1.054 ml, 14.45 mmol) was added, and the reaction was stirred at 60° C. for 3 hours to achieve completion.
The reaction mixture was concentrated, and the crude was triturated in Hexane and filtered to give methyl 4-formyl-3-hydroxybenzoate (1.3 g, 7.22 mmol, 100percent yield). MS/ESI+ 181.04 [MH]+
85% Reflux 4-Formyl-3-hydroxybenzoic acid (5 g, 30 mmol) was suspended in methanol (70 mL), and treated with thionyl chloride (3.29 mL 45 mmol) dropwise. The mixture was heated to reflux overnight. Concentrated to dryness, and 50 mL of toluene was added, and concentrated again. The residue was recrystallized from ethyl acetate-hexane. A total of 4.8 g (85percent) of methyl 4-formyl-3-hydroxybenzoate was obtained.
Reference: [1] Patent: US2014/155391, 2014, A1, . Location in patent: Paragraph 0617; 0618
[2] Patent: US2012/245144, 2012, A1, . Location in patent: Page/Page column 105
[3] Journal of the American Chemical Society, 1955, vol. 77, p. 973,979
[4] Journal of Medicinal Chemistry, 1969, vol. 12, # 3, p. 420 - 424
[5] Bioorganic and Medicinal Chemistry, 2001, vol. 9, # 5, p. 1175 - 1183
  • 2
  • [ 71780-40-0 ]
  • [ 24589-98-8 ]
YieldReaction ConditionsOperation in experiment
37% With sodium tetrahydroborate; palladium 10% on activated carbon; oxygen; potassium carbonate In methanol; water To a solution of 250 mg (1.37mmol) methyl3-hydroxy-4-(hydroxymethyl)benzoate in 3 mL 10percent aqueous methanol was added 73 mg (10percentloading, 0. 034 mmol, 2. 5 molpercent) Pd/C, 567 mg ( 4.11 mmol, 3 eq) potassium carbonate,and 5.2 mg (0.137, 0.1 eq) sodium borohydride, and the mixture was stirred under anatmosphere of oxygen overnight. Then, the mixture was diluted with dichloromethaneand filtered. The mixture was concentrated in vacuo, partitioned between ethyl acetateand water, and the aqueous layer extracted two more times with ethyl acetate. The combined organic phases were then dried over sodium sulfate. The solvent was removedunder reduced pressure and the product was purified by column chromatography. 92 mg(0.506 mmol, 37percent) of the methyl4-formyl-3-hydroxybenzoate were obtained as a whitesolid. Rf(25percent EtOAc, 75percent Hexanes) = 0.50; 1H NMR (600 MHz, Chloroform-d) 8 10.94(s, 1H), 9.98 (s, 1H), 7.69-7.63 (m, 3H), 3.94 (s, 3H). 13C NMR (126 MHz, Chloroform-d) 8196.44, 165.67, 161.24, 137.30, 133.62, 122.86, 120.40, 119.12, 52.69. HRMS: m/z(+H+). calc'd: 181.0495, found: 181.0494.
Reference: [1] Patent: WO2018/191360, 2018, A1, . Location in patent: Page/Page column 63
[2] Journal of Materials Chemistry, 2005, vol. 15, # 44, p. 4746 - 4752
  • 3
  • [ 100-97-0 ]
  • [ 19438-10-9 ]
  • [ 24589-98-8 ]
  • [ 131524-43-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1994, vol. 42, # 10, p. 2170 - 2173
[2] Patent: EP1489078, 2004, A1, . Location in patent: Page 195
[3] Patent: EP1666478, 2006, A1, . Location in patent: Page/Page column 90
[4] Journal of the American Chemical Society, 2013, vol. 135, # 46, p. 17408 - 17416
  • 4
  • [ 67-71-0 ]
  • [ 1560893-80-2 ]
  • [ 24589-98-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2334 - 2356
  • 5
  • [ 6342-72-9 ]
  • [ 24589-98-8 ]
Reference: [1] Journal of Materials Chemistry, 2005, vol. 15, # 44, p. 4746 - 4752
[2] Patent: WO2018/191360, 2018, A1,
  • 6
  • [ 99-06-9 ]
  • [ 24589-98-8 ]
Reference: [1] Journal of Medicinal Chemistry, 1969, vol. 12, # 3, p. 420 - 424
  • 7
  • [ 157942-12-6 ]
  • [ 24589-98-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2334 - 2356
  • 8
  • [ 619-12-5 ]
  • [ 18107-18-1 ]
  • [ 24589-98-8 ]
Reference: [1] Patent: WO2006/90850, 2006, A1, . Location in patent: Page/Page column 65
  • 9
  • [ 1571-08-0 ]
  • [ 24589-98-8 ]
  • [ 42137-51-9 ]
Reference: [1] Tetrahedron, 1996, vol. 52, # 11, p. 3889 - 3896
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 24589-98-8 ]

Aryls

Chemical Structure| 4670-56-8

[ 4670-56-8 ]

Methyl 2-hydroxy-4-methylbenzoate

Similarity: 0.98

Chemical Structure| 2150-46-1

[ 2150-46-1 ]

Methyl 2,5-dihydroxybenzoate

Similarity: 0.98

Chemical Structure| 6342-72-9

[ 6342-72-9 ]

Dimethyl 2-hydroxyterephthalate

Similarity: 0.98

Chemical Structure| 808123-00-4

[ 808123-00-4 ]

3-Hydroxy-4-(methoxycarbonyl)benzoic acid

Similarity: 0.98

Chemical Structure| 29602-00-4

[ 29602-00-4 ]

2-Hydroxy-4-(methoxycarbonyl)benzoic acid

Similarity: 0.98

Aldehydes

Chemical Structure| 42137-51-9

[ 42137-51-9 ]

Methyl 4-formyl-2-hydroxybenzoate

Similarity: 0.98

Chemical Structure| 24589-99-9

[ 24589-99-9 ]

Methyl 3-formyl-4-hydroxybenzoate

Similarity: 0.97

Chemical Structure| 328030-95-1

[ 328030-95-1 ]

Methyl 3,5-diformyl-4-hydroxybenzoate

Similarity: 0.97

Chemical Structure| 41489-76-3

[ 41489-76-3 ]

Methyl 5-formyl-2-hydroxybenzoate

Similarity: 0.95

Chemical Structure| 74733-24-7

[ 74733-24-7 ]

Methyl 4-formyl-3-methoxybenzoate

Similarity: 0.93

Esters

Chemical Structure| 4670-56-8

[ 4670-56-8 ]

Methyl 2-hydroxy-4-methylbenzoate

Similarity: 0.98

Chemical Structure| 2150-46-1

[ 2150-46-1 ]

Methyl 2,5-dihydroxybenzoate

Similarity: 0.98

Chemical Structure| 6342-72-9

[ 6342-72-9 ]

Dimethyl 2-hydroxyterephthalate

Similarity: 0.98

Chemical Structure| 808123-00-4

[ 808123-00-4 ]

3-Hydroxy-4-(methoxycarbonyl)benzoic acid

Similarity: 0.98

Chemical Structure| 29602-00-4

[ 29602-00-4 ]

2-Hydroxy-4-(methoxycarbonyl)benzoic acid

Similarity: 0.98